drugset / Trial / NCT01204242

IRB-HSR# 13957: IV Lidocaine for Patients Undergoing Primary Breast Cancer Surgery:

NCT01204242

Phase 2 Completed 78 enrolled University of Virginia
RandomizedParallel-groupQuadruple-blindPrevention

Summary

The purpose of this study is to determine whether a local anesthetic drug (lidocaine) given during anesthesia intravenously (IV) through a needle in your vein,), can: 1. Help decrease pain after surgery. 2. Have you need less pain medication. 3. Have less side effects like nausea and vomiting following your surgery. 4. Help to prevent chronic pain. 5. Affect recurrence of cancer after surgery.

Timeline

Start
2009-08-01
Primary completion
2018-11-08
Completion
2018-11-08

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Lidocaine Other / unclassified 8 mg/ml Intravenous

Indications